Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients ? The IMPROVED multi-centre study | Zendy

Christiane E. Angermann | Zendy; Stefan Störk | Zendy; Angelika CostardJäckle | Zendy; T.J. Dengler | Zendy; Uwe Siebert | Zendy; Gero Tenderich | Zendy; Axel Rahmel | Zendy; Edward M. Schwarz | Zendy; Herbert Nägele | Zendy; Fritz Wagner | Zendy

Open Access

Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients ? The IMPROVED multi-centre study

Author(s) -

Christiane E. Angermann,

Stefan Störk,

Angelika CostardJäckle,

T.J. Dengler,

Uwe Siebert,

Gero Tenderich,

Axel Rahmel,

Edward M. Schwarz,

Herbert Nägele,

Fritz Wagner

Publication year - 2004

Publication title -

european heart journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.336

H-Index - 293

eISSN - 1522-9645

pISSN - 0195-668X

DOI - 10.1016/j.ehj.2004.06.032

Subject(s) - medicine , renal function , azathioprine , urology , creatinine , immunosuppression , kidney disease , transplantation , kidney , subclinical infection , trough level , diabetes mellitus , heart transplantation , gastroenterology , endocrinology , tacrolimus , disease

This comparative prospective multi-centre study evaluated efficacy and safety of cyclosporine A downtitration in heart transplant recipients with chronic renal dysfunction potentially attributable to cyclosporine (n=161).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research